Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis

Neuro-Oncology(2022)10.1093/neuonc/noac262Source: DataRank Database

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis is a research paper published in Neuro-Oncology (2022). On theSindex it has a DataRank of 0.572. It has been cited 17 times, with 16 citing works in its 1-hop citation network.

N/A

0.572DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access17 citations · 16 citing works in its network

Download PDF

Cite:

Linked data & code

refsnp nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT01372774

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 1.91)OA: hybridTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 76%Citation Network 24%

Base Score Contribution

0.434

From this paper's citation signal

Citation Network Contribution

0.138

From 11 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 16 citers.

The impact of citicoline on brain mitochondrial dysfunction induced in rats after head irradiation
Scientific Reports20253 citations52 referencesContributes 0.027
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
International Journal of Molecular Sciences202323 citations136 referencesContributes 0.023
Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial
Clinical Lung Cancer20241 citations31 referencesContributes 0.022
Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach
Neuro-Oncology20253 citations75 referencesContributes 0.018
A brain metastasis liquid biopsy: Where are we now?
Neuro-Oncology Advances202412 citations139 referencesContributes 0.018

Authors (25)

S. Keith Anderson ORCID,Karla V. Ballman ORCID,Erin Twohy ORCID,Katharine Dooley ORCID,Wen Jiang ORCID

Live enrichment

PubMed:36472389 PMC:PMC10237411 OpenAlex:https://openalex.org/W4310786023

National Cancer Institute

Grant: U10CA180821

National Cancer Institute

Grant: U10CA180882

National Cancer Institute

Grant: U24CA196171

National Cancer Institute

Grant: UG1CA233180

National Cancer Institute

Grant: UG1CA233329

National Cancer Institute

Grant: UG1CA232760

National Cancer Institute

Grant: U10CA180863

National Cancer Institute

Grant: P30CA016672

NCI NIH HHS

Grant: P30 CA015083

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 3U10CA180821-02S2

Alliance for Clinical Trials in Oncology Operations Center

National Institutes of Health

Grant: 5U10CA180882-02

Statistics and Data Center for the Alliance for Clinical Trials in Oncology

National Institutes of Health

Grant: 3UG1CA232760-06S1

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)

National Institutes of Health

Grant: 5UG1CA233180-02

NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care

National Institutes of Health

Grant: 3U24CA196171-04S1

THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE

National Institutes of Health

Grant: 5U10CA180863-08

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network

National Institutes of Health

Grant: 5UG1CA233329-06

UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

FWCI

1.91

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/neuro-oncology/article-pdf/25/6/1123/50513382/noac262.pdf

publisherhttps://academic.oup.com/neuro-oncology/article-pdf/25/6/1123/50513382/noac262.pdf

publisherhttps://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac262/49689891/noac262.pdf

journalhttps://doi.org/10.1093/neuonc/noac262

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36472389

Fields of Study

Brain Metastases and TreatmentLung Cancer Research StudiesCancer-related cognitive impairment studies03 medical and health sciences0302 clinical medicineHumansBrain NeoplasmsRetrospective StudiesAmyloid beta-PeptidesCranial IrradiationRadiosurgeryCognitive Dysfunction

MeSH Terms

Brain NeoplasmsHumansRetrospective StudiesAmyloid beta-PeptidesCranial IrradiationRadiosurgeryCognitive Dysfunction

Keywords

NeurocognitiveMedicineInternal medicineCognitive declineBrain metastasisOncologyRadiosurgeryRadiation therapyApolipoprotein EClinical endpointGastroenterologyRandomized controlled trialDementiaCognitionMetastasisCancerPsychiatryDiseaseApolipoproteinsAmyloid betaBrain metastasesMedical SciencesAmyloid beta-PeptidesBioinformaticsBrain Neoplasms610Biomedical InformaticsMedical SpecialtiesMedicine and Health SciencesHumansCognitive DysfunctionCranial IrradiationRetrospective Studies